M. Lichtenstein

发表

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis

J. Berg, J. Crowley, Jia Wen, 2022, medRxiv.

Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.

P. Sullivan, James P Evans, J. Berg, 2018, The American journal of psychiatry.

Clinical features and SPECT scanning in presumed cortico-basal ganglionic degeneration

P. Desmond, E. Storey, J. Lloyd, 1995, Journal of Clinical Neuroscience.

Distal infantile neuroaxonal dystrophy – a new familial variant with perineuronal argyrophilic bodies

C. Nordborg, J. Månsson, M. Kyllerman, 2001, Acta Neuropathologica.

A prospective study of cortical scarring in acute febrile pyelonephritis in adults: clinical and bacteriological characteristics.

P. Kincaid‐smith, K. Fairley, M. Lichtenstein, 1995, Clinical Nephrology.

Treatment-resistant schizophrenia and staff rejection.

U. Heresco-Levy, M. Ermilov, D. Blander, 1999, Schizophrenia bulletin.

Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature

P. Sullivan, J. Berg, J. Crowley, 2020, Translational Psychiatry.

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

D. Javitt, G. Silipo, U. Heresco-Levy, 1999, Archives of general psychiatry.

Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome

P. Sullivan, J. Berg, J. Crowley, 2020, Schizophrenia Research.

M94 THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA

P. Sullivan, J. Berg, J. Crowley, 2019, European Neuropsychopharmacology.